Updates are available Correction dated 2024-03-22
Click to view Correction: https://doi.org/10.1007/s11060-024-04635-0
-
Authors
Andrews, Carrie E. https://orcid.org/0000-0001-9688-4098
Zilberberg, Jenny https://orcid.org/0000-0002-4139-2616
Perez-Olle, Raul https://orcid.org/0000-0001-9313-3694
Exley, Mark A. https://orcid.org/0000-0002-5088-1032
Andrews, David W. https://orcid.org/0000-0002-7939-7471
-
Funding
Funding for this research was provided by:
National Institutes of Health (T32GM008562-28)
- License Information
-
More Information
Article History
Received: 10 August 2023
Accepted: 25 October 2023
First Online: 29 November 2023
Change Date: 22 March 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11060-024-04635-0
Declarations
:
: David W. Andrews, MD; Mark A. Exley, PhD; Jenny Zilberberg MS, PhD; and Raul Perez-Olle, MD, PhD are employees of and holds stock/stock options of Imvax.
